Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    gastroenterology

    Gastrointestinal haemorrhage

    Also known as: Gastrointestinal bleeding, GI haemorrhage, Digestive tract bleeding, Upper gastrointestinal bleeding, Lower gastrointestinal bleeding

    Gastrointestinal haemorrhage encompasses bleeding within the digestive tract, ranging from occult loss and anaemia to life-threatening exsanguination. Aetiology includes peptic ulceration, oesophageal varices, inflammation, vascular lesions, and malignancy. Clinical priority mandates haemodynamic stabilisation and source-directed intervention. Acupuncture and Chinese herbal medicine are contraindicated in the acute phase and must not substitute for emergency medical care. Following stabilisation and formal clearance from the treating medical team, traditional pattern differentiation may inform adjunctive support for residual sequelae. The cited evidence provides no data regarding the efficacy of acupuncture or herbs for this condition: one record is an abdominal-pain review protocol, while others describe pharmacovigilance signals regarding medication-related risks rather than established causation or incidence.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere strictly to hospital discharge protocols, ensuring attendance at all follow-up investigations, endoscopies, and specialist consultations, irrespective of symptom resolution.
    • •Resume oral intake as directed by the medical team, prioritising easily digestible meals and consulting a dietitian if nutritional intake is suboptimal.
    • •Abstain from alcohol throughout the recovery period and avoid non-prescribed non-steroidal anti-inflammatory drugs (NSAIDs), herbs, or supplements pending a formal medication review.
    • •Manage exertion levels and monitor stools, vitality, and orthostatic symptoms; maintain a current, accessible list of all medications.

    Cautions & Contraindications

    See sources
    • •Active bleeding, suspected rebleeding or medical instability excludes acupuncture and herbal care: arrange emergency assessment. This is a precautionary exclusion; the supplied protocol concerns IgA vasculitis abdominal pain and supplies no evidence of safety or efficacy in gastrointestinal haemorrhage.[]
    • •Vorapaxar or other antithrombotic use requires explicit medication and bleeding-risk review before any recovery-phase intervention. Do not independently stop prescribed antithrombotic treatment. The cited record reports haemorrhagic signals for vorapaxar, not specific herb–drug interaction studies.[]
    • •During immune-targeted hepatocellular carcinoma treatment or BCR-ABL inhibitor therapy, do not introduce herbs or proceed with needling without oncology clearance and review of blood counts, liver function and current bleeding risk. The cited signals support vigilance but do not quantify acupuncture-related risk.[,]

    When to reassess or seek care again

    See sources

    Emergency presentations require immediate referral, not a TCM review appointment. After documented complete stabilisation and treating-team clearance, review any optional symptom-focused care within 1–2 weeks, tracking fatigue on a 0–10 scale, appetite, meal tolerance, sleep duration and function. Follow haemoglobin and iron studies only on the medical team's schedule; improved symptoms do not establish correction of anaemia. Stop adjunctive care and refer urgently for recurrent bleeding, worsening dizziness, palpitations or declining function. If there is no meaningful symptom improvement within 2–4 weeks, discontinue and seek medical reassessment.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. BMJ open · 2025
    2. Journal of gastrointestinal cancer · 2026
    3. PloS one · 2026
    4. Frontiers in oncology · 2026
    5. Cochrane Database of Systematic Reviews · 2015

      Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.

    6. JAMA Surgery · 2023

      Randomised trial including ST36 for postoperative gastrointestinal recovery.

    7. World Health Organization · 2008

      Standard point locations used for the adjunctive points listed.

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.